The clinical spectrum of statin-related myopathies varies widely from asymptomatic creatinine kinase (CK) elevations, pain, or muscle weakness to severe forms of necrotizing immune-mediated myopathy by anti-3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) antibodies [1]. This evidence concerns the gene HMGCR and myopathy.